.svg){kind=small}
Where to Buy
Farmaceutical Rx (Frx) is stocked at 49 licensed dispensaries across Ohio and Pennsylvania, 35 of them in Ohio, with the deepest coverage in Cincinnati, Columbus, Athens, Cleveland, and Oxford. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Farmaceutical Rx (Frx) concentrated 99.51% of sales in Flower, up via an 18.16% month-over-month lift in Flower against a concurrent 93.29% month-over-month drop in Edible, while year-over-year Flower declined 67.56% and Edible fell 95.94%. The brand’s overall average price fell 10.07% year over year to $33.04, with Flower pricing at $33.55, indicating mix is tilting further toward higher-ticket Flower even as total brand sales declined 69.61% year over year. With Flower holding 99.51% share and Edible at 0.49%, the near-elimination of Edible after a 93.29% month-over-month contraction implies Farmaceutical Rx (Frx) is functioning as a single-category operator, making short-term growth dependent on sustaining the 18.16% month-over-month momentum in Flower despite its 67.56% year-over-year contraction.
The mix shift concentrates risk in Ohio Flower, where Farmaceutical Rx (Frx) ranked 46 in Flower, and where month-over-month recovery of 18.16% must overcome a 67.56% year-over-year gap to stabilize share. The 10.07% year-over-year price decrease alongside a 65.97% two-year sales contraction suggests pricing is being used as a volume lever in Flower, but the 95.94% year-over-year collapse in Edible removes a diversification buffer. Net effect: Farmaceutical Rx (Frx)’s positioning hinges on deepening penetration in rank 46 Flower while either reintroducing Edible above its current 0.49% share or accepting a single-category footprint with tighter price-volume tradeoffs.
Competitive Landscape
Farmaceutical Rx (Frx) ranks #46 in OH Flower in August 2026, down 25 places year over year from #21, after a near-term rise from #59 three months ago to #46 now; that trajectory contrasts with Klutch Cannabis moving to #1 with a year-over-year rank change from #19 to #1 and sales up 362.3%, and with RYTHM advancing from #8 to #2 while posting 27.3% sales growth; compared with Riviera Creek, which edged from #4 to #3 despite a 28.4% sales decline, Farmaceutical Rx (Frx) also sits 25 ranks below its August 2025 peak of #21 and 41 places behind the current category leader, implying the brand has shifted from prior upper-tier positioning toward lower mid-tier status despite a short-term rebound.
Notable Products
Animal Face (2.83g) delivered the standout surge in August 2026 with +345.8% MoM to rank 3, while GMO Minis (5.66g) jumped +285.1% MoM to seize rank 1, and Trop Cookie Minis (5.66g) fell −74.1% MoM to rank 8. GMO (2.83g) advanced +140.4% MoM into rank 2, and four of the top ten are Flower Minis or 2.83g flower SKUs, indicating a tilt toward smaller-size purchases over bulk formats. Despite Ghost OG (28.3g) entering at rank 5, the combined rank positions of 1, 2, and 3 for smaller sizes suggest velocity is concentrating in trial and repeat packs rather than large ounce buys. The pattern implies Farmaceutical Rx (Frx) is shifting assortment power to compact Flower formats that can scale quickly with promo or distribution pulses.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
